To acquire the data concerning the tolerable upper intake level which prevents health problems from an excessive intake of pantothenic acid, an animal experiment was done. Rats of the Wistar strain (male, 3wk old) were fed on a diet which contains 0%, 0.0016% (control group), 1%, or 3% calcium pantothenate for 29d. The amount of weight increase, the food intake, and the organ weights were measured, as well as the pantothenic acid contents in urine, the liver and blood. Moreover, to learn the influence of excessive pan tothenic acid on other water-soluble vitamin metabolism, thiamin, riboflavin, a vitamin B6 catabolite, the niacin catabolites, and ascorbic acid in urine were measured. As for the 3% addition group, enlargement of the testis, diarrhea, and hair damage were observed, and the amount of weight increase and the food intake were less than those of the control group. However, abnormality was not seen in the 1% addition group. The amount of pantothenic acid in urine, the liver, and blood showed a high correlation with intake level of pantothenic acid. It was only for 4-pyridoxic acid, a vitamin B6 catabolite, in urine that a remarkable dif ference was observed against the control group. Moreover, the (2-Py+4-Py)/MNA excretion ratio for these metabolites of the nicotinamide also indicated a low value in the 3% pan tothenic acid group. As for the calcium pantothenate, it was found that the 3% level in the diet was the lowest-observed-adverse-effect-level (LOAEL) and the 1% level was the no observed-adverse-effect-level (NOAEL).
Pantothenic acid (PaA), a vitamin, is essential for humans and animals for growth and normal physiolog ical functions. It is an integral part of the acylation car riers, CoA and acyl carrier proteins, which are involved in more than 100 different metabolic pathways includ ing energy metabolism of carbohydrates, proteins and lipids, and the synthesis of lipids, neurotransmitters, and steroid hormones (1, 2) .
It was reported that PaA deficiency induced in exper imental animals when fed on a diet without PaA led to growth retardation with reduced food intake (3, 4) and functional impairments in all systems (5) (6) (7) (8) (9) (10) (11) (12) (13) . PaA defi ciency has also been induced in humans by use of a metabolic antagonist, w-methyl PaA along with a PaA deficient diet (14) : Signs and symptoms reported include depression, personality changes, cardiac insta bility, frequent infection, fatigue, abdominal pains, sleep disturbances and neurological disorders including numbness, paresthesia (abnormal sensation such as "burning feet" syndrome) , muscle weakness and cramps. Naturally occurring PaA deficiency in humans is very rare and has been observed only in cases of severe malnutrition: World War II prisoners in the Phil lipines, Burma, and Japan experienced numbness and painful burning and tingling in their feet ("burning feet" syndrome), which was relieved specifically by PaA administration (15) . The cause of this syndrome must originate from stresses because PaA involves the forma tion of adrenocortical hormones (16) . Therefore, the specific PaA deficiency in humans would be "burning feet" syndrome. There is an interesting hypothesis that the formation of ketone bodies under fasting conditions induces a deficiency of cellular PaA (17) . Supplementa tion of this vitamin would facilitate complete catabolism of fatty acids and thus the formation of ketone bodies could be circumvented. Oral contraceptives (birth con trol pills) containing estrogen and progestin may increase the requirement for PaA (18) . Recently, a report that PaA protects cells and organs against perox idative damage by increasing the content of cell glu tathione was published (19) .
The reports (17) (18) (19) that pantothenic acid prevents stresses, peroxidation reactions and the formation of the ketone bodies predict a possibility that the intake of pantothenic acid will increase more and more in the future.
PaA is not known to be toxic in humans. The only adverse effect noted was diarrhea resulting from very high intakes of 10 to 20g/d of calcium D-pantothenate (18) . However, there is one case report of life-threaten ing eosinophilic pleuropericardial effusion in an elderly woman who took a combination of 10 mg/d of biotin E-mail; kshibata@shc.usp.ac.jp and 300mg/d of PaA for 2mo (20) . In rats, there are two reports on the effect of excess PaA: one details changes in hepatocellular lipid production because of an excess of PaA (21) and the other is a report on adrenocortical alterations induced by deficiency and excess of PaA (22) . In the present paper, we report the effects of administering excess PaA to rats to acquire data concerning the tolerable upper intake level to pre vent health problems especially the effects on the other water-soluble vitamin metabolisms.
MATERIALS AND METHODS
Chemicals. Vitamin-free milk casein, sucrose, and L methionine were purchased from Wako Pure Chemical Industries (Osaka, Japan). Corn oil was purchased from Ajinomoto (Tokyo, Japan). Gelatinized cornstarch, the mineral mixture (AIN-93M) (23) Male rats of the Wistar strain (3wk old with a body weight of around 40 g) were obtained from CLEA Japan, Inc. (Tokyo, Japan) and immediately placed in individ ual metabolic cages (CT-10; CLEA Japan, Inc.). They were then divided into four groups and fed ad libitum for 29d, one group with a PaA-free, 20% casein diet, and the others with the same diet+0.0016% PaA-Ca (used as the control group), +1.0% PaA-Ca, or+3.0% PaA-Ca ( Table 1 ). Analyses.
Vitamin B1 (thiamin): The determination of vitamin B, in urine was measured by the HPLC-post labeled flu orescence method of Kimura et al. (28) .
Vitamin B2 (riboflavin): Urinary concentration of riboflavin was analyzed according to the method of Ohkawa et al. (29) .
4-PIC: Urinary excretion of 4-PIC, which is a catabo lite of vitamin B6, was determined according to the method described by Gregory and Kirk (30) .
Niacin: The quantities of Nam, 2-Py and 4-Py in urine were measured simultaneously by the HPLC method of Shibata et al. (25) . The content of MNA was measured by the method of Shibata (31) .
Pantothenic acid: The content of free pantothenic acid in urine was directly measured by using Lactobacil lus plantarum ATCC 8014 (26) .
Ascorbic acid: The contents of the reduced and oxi dized ascorbic acids and 2, 3-diketoglutaric acid were measured by the method of Kishida et al. (32) .
CoA: The content of CoA in liver was measured by the methods of Ailed and Guy (33) .
Statistical analysis.
For the statistical evaluation, the significance of the differences in the mean concentra tions among groups was treated with ANOVA and when the analysis of ANOVA was significant, the Tukey Kramer multiple comparisons test was performed. Dif Table 1 . The composition of the diets.
ferences of p<0.05 were considered to be statistically significant. Instat software (version 2.00; obtained from GraphPad Software, Inc., San Diego, CA, USA) was used for all analyses.
RESULTS
Effects of excessive PaA administration on the body weight gain and food intake in rats The diet containing 0.0016% PaA-Ca was considered as the control. The body weight gain and food intake were almost the same between the control and the 0% PaA-Ca groups in the first 5-7d; however, these signifi cantly decreased in the 0% group compared with the control after that day as shown in Fig. 1 . The result means that some days are needed for appearance of PaA-deficiency. On the other hand, the body weight gain and food intake of the rats fed on the 3% PaA-Ca diet were significantly lower than those in the control group, especially in the initial 5 d of the experiment with the food intake ( Fig. 1) . The food intakes in the 3% group became similar in amount with those of the con trol group from around day 2 0 of the experiment. The body weight gains in the control and the 3% PaA groups were almost the same from day 7. This finding complies with the possibility that the rats acquire a detoxification process of PaA by exposure to an excess amount of PaA. No adverse effects were observed in the rats fed on the 1% PaA-Ca diet. Effects of excessive PaA administration on the tissue weights of rats Table 2 shows the tissue weights of the rats fed on the diets supplemented with various amounts of PaA-Ca.
The values were expressed as g/100g of body weight of rat. The weights of heart, liver, and kidneys revealed no significant difference among the four groups. In the present experiment, the group fed on the 0.0016% PaA-Ca diet is the control group. The brain and testis weights were significantly higher in the PaA-deficient group than in the other PaA-containing groups. In the comparison between the control and 1% PaA-Ca groups, all of the measured tissue weights were almost the same.
But the weights of lung and spleen were significantly higher in the 3% group than in the control group.
Effects of excessive PaA administration on the PaA contents in urine and liver and the CoA content in liver phate) and NAD (nicotinamide adenine dinucleotide) were concerned in the metabolism of glucides, amino acids, and fatty acids as well as CoA. Thus, the excessive PaA administration had effects on the metabolism of vitamin B1, vitamin B2, vitamin B6, and niacin (vitamin B3). Niacin and PaA are especially concerned with energy metabolism. The effects of excessive administration of PaA on the metabolism of the de novo nicotinamide synthetic pathway (tryptophan-quinolinic acid path way) were investigated. As results, the respective uri nary excretion of kynurenic acid, anthranilic acid, xan thurenic acid, 3-hydroxyanthranilic acid, and quinolinic acid was not changed by the administration of excessive PaA (data not shown). The excessive PaA administra tion did not affect the total urinary excretion of nicotin amide, MNA, 2-Py, and 4-Py (Fig. 3A) , though it did affect the urinary excretory ratio of (2-Py+4-Py)/MNA (Fig. 3B ), in comparison with the control group. The decreased ratio means that the excessive PaA induced some adverse effects in the rats, because the low value of the ratio of (2-Py+4-Py)/MNA indicates retrogres sion of the metabolism of nicotinamide. Furthermore, the present data (Fig. 3) show that the deficiency of PaA affects the nicotinamide metabolism. The decreased total urinary excretion in the 0% PaA group compared with the control means that PaA defi ciency increases the demand for niacin requirement. Figure 4 shows the effects of PaA administration on the urinary excretion of vitamin B1, vitamin B2, and 4 PIC (a catabolite of vitamin B6). The urinary excretion of vitamin B1 and 4-PIC decreased according to the increase in the intake of PaA, while that of vitamin B2 did not. Effects of excessive PaA administration on the urinary excretion of ascorbic acid
In rats, ascorbic acid can be made from glucose, so ascorbic acid is not a vitamin. Therefore, many reports have been published that the production of ascorbic acid is changeable by many factors.
In the present experiment, the urinary excretion of ascorbic acid was not different among the four groups as shown in Fig. 5 .
DISCUSSION
PaA is an integral part of CoA, which is an essential coenzyme in a variety of reactions that sustain life. CoA is required for biochemical reactions that generate energy from food (fats, carbohydrates, and proteins). The synthesis of essential fats, cholesterol, and steroid hormones requires CoA, as does the synthesis of the neurotransmitter, acetylcholine, and the hormone, melatonin (2) . Metabolism of a number of drugs and toxins by the liver requires CoA (34) . Most acetylated proteins in the body have been modified by the addition of an acetate group that was donated by CoA. Protein acetylation affects the 3-dimensional structure of pro teins, potentially altering their function, the activity of peptide hormones, and appears to play a role in cell division and DNA replication. Protein acetylation also affects gene expression by facilitating the transcription of mRNA. A number of proteins are also modified by the attachment of long-chain fatty acids donated by CoA. These modifications are known as protein acylation, and appear to play a central role in cell signaling (1, 2) .
As mentioned in the introduction, supplementation of PaA would facilitate complete catabolism of fatty acids (17) and oral contraceptives (birth control pills) containing estrogen and progestin may increase the requirement for PaA (18) . Furthermore, PaA protects cells and organs against peroxidative damage by increasing the content of cellular glutathione (19) . These findings induce use of excessive PaA for preven tion against stresses, peroxidation, the formation of ketone bodies and so on.
The present experiments in rats clearly indicated that excessive intake of PaA had an adverse effect on body weight gain (Fig. 1A) , food intake (Fig. 1B) , the excre tory ratio of (2-Py+4-Py)/MNA (Fig. 3B) , the urinary excretion of vitamin Bl (Fig. 4A) , and the urinary excre tion of 4-PIC (Fig. 4C) as well as PaA deficiency. The level causing the no-observed-adverse-effect level (NOAEL) in the rats was 1% in the diet and that causing the lowest-observed-adverse-effect-level (LOAEL) was 3% in the diet. The rats in the 1% PaA group consumed aroundl6g/d of their diet during day 20 to day 29 and the mean body weight during the days was about 160g. So, the PaA intake was calculated as 3,000mg/ kg body weight a day. The rats in the 3% PaA group consumed around 16g/d during day 20 to day 29 and the mean body weight during the days was about 180g. So, the PaA intake was calculated as 1,000mg/ kg body weight a day, which is a proposed acceptable daily intake of PaA-Ca for rats. Although the data were not shown in the present experiments, we also done an experiment in which rats were fed on a 5% PaA diet. But, four of the five rats died with sever diarrhea within 2d of starting the diet. The surviving rat, although maintaining the same diet, was restored to vigor after 1 wk and gained as much weight as the control. This phe nomenon looked like the results in the 3% PaA group (Fig. 1A) . It is known that the ascorbic acid formation increases when the rats are exposed to xenobiotics to metabolize and excrete into urine (36) . A large amount of PaA administration to the rats did not induce the formation of ascorbic acid (Fig. 5) . So, excess amount of PaA is not recognized as xenobiotic in the rats.
In conclusion, the NOAEL of PaA, an essential part of CoA that sustains life was 1% in the dietary level and the LOAEL was 3% in the dietary level. In a daily intake per kg of body weight of rat, the NOAEL was around 1,000mg, while the LOAEL was around 3,000mg. If a safety factor would be 100 (species difference 10, indi vidual difference 10) (37), the tolerable upper intake level is around 10mg/kg body weight a day. We would propose 10mg of PaA-Ca/kg body weight a day as a tentative tolerable upper intake level.
